Yuanyuan Li

11PUBLICATIONS
39CO-AUTHORS
PharmacogenomicsNanotoxicology, health and safetyBehavioural epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Public health nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 10, 2026
HDM1002 in Chinese Adults With Overweight/Obesity: A Randomized, Placebo-Controlled, Ascending-Dose Phase 1b Study.

Hongrong Xu, Wei Hu, Lin Zhao

|May 29, 2025
Association of tirzepatide with cardiometabolic benefits in Chinese adults: post hoc subgroup analysis of SURMOUNT-CN study.

Lin Zhao, Hong Chen, Zhifeng Cheng

|May 07, 2025
Predicting 10-year risk of type 2 diabetes in Chinese people with overweight or obesity treated with Tirzepatide: Post hoc analysis of SURMOUNT-CN trial.

Lin Zhao, Feng Tao, Zhifeng Cheng

|Jan 22, 2025
Dapagliflozin plus calorie restriction for remission of type 2 diabetes: multicentre, double blind, randomised, placebo controlled trial.

Yuejun Liu, Ying Chen, Jianhua Ma

|Aug 30, 2024
Prevalence and Risk Factors of Chronic Kidney Disease in Patients With Type 2 Diabetes in China: Cross-Sectional Study.

Lixin Shi, Yaoming Xue, Xuefeng Yu

|Apr 24, 2023
Use of basal insulin in the management of adults with type 2 diabetes: An Asia-Pacific evidence-based clinical practice guideline.

Linong Ji, Yingying Luo, Yong Mong Bee

Pageof 2

Frequent Collaborators

2 joint publications

Khue Thy Nguyen

2 joint publications

Marisa Deodat

2 joint publications

Alice Pik Shan Kong

2 joint publications

Soo Lim